Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5SBP3

Entry ID Method Resolution Chain Position Source
AF-Q5SBP3-F1 Predicted AlphaFoldDB

No variants for Q5SBP3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5SBP3

No associated diseases with Q5SBP3

3 regional properties for Q5SBP3

Type Name Position InterPro Accession
domain RNA 3'-terminal phosphate cyclase, insert domain 180 - 273 IPR013791
conserved_site RNA 3'-terminal phosphate cyclase-like, conserved site 154 - 164 IPR020719
domain RNA 3'-terminal phosphate cyclase domain 9 - 324 IPR023797

Functions

Description
EC Number 4.2.3.26 Acting on phosphates
Subcellular Localization
  • Plastid, chloroplast
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
chloroplast A chlorophyll-containing plastid with thylakoids organized into grana and frets, or stroma thylakoids, and embedded in a stroma.

3 GO annotations of molecular function

Name Definition
magnesium ion binding Binding to a magnesium (Mg) ion.
R-linalool synthase activity Catalysis of the reaction: geranyl diphosphate + H(2)O = (R)-linalool + diphosphate.
terpene synthase activity Catalysis of the formation of cyclic terpenes through the cyclization of linear terpenes (e.g. isopentenyl-PP, geranyl-PP, farnesyl-PP and geranylgeranyl-PP) containing varying numbers of isoprene units.

1 GO annotations of biological process

Name Definition
diterpenoid biosynthetic process The chemical reactions and pathways resulting in the formation of diterpenoid compounds, terpenoids with four isoprene units.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSCARITVTL PYRSAKTSIQ RGITHCPALL RPRFSACTPL ASAVPLSSTP LINGDNSPLK
70 80 90 100 110 120
NTHQHVEERS SKRREYLLEE TARKLQRNDT ESVEKLKLID NIQRLGIGYY FEDAIDAVLR
130 140 150 160 170 180
SPFSAEEEED LFTAALRFRL LRHNGIQVTP EIFLKFKDER GEFDESDTLG LLSLYEASNL
190 200 210 220 230 240
GVTGEEILEE AMEFAEPRLR RSLSELAAPL RSEVAQALDV PRHLRMARLE ARRFIEQYGK
250 260 270 280 290 300
QSDHDGDLLE LAILDYNQVQ AQHQSELTEI TRWWKQLGLV EKLGFGRDRA LECFMWTMGI
310 320 330 340 350 360
LPHPKYSSSR IESAKAAALL YVIDDIFDTY GKMDELILFT DAIRRWDLEA MEGLPEYMKI
370 380 390 400 410 420
CYMALYNTTN EICYRVLKDT GRIALPYLKS VWIETIEAYM VEVKWFSGGS APKLEEYIEN
430 440 450 460 470 480
GASTVGAYMV LVHLFFLIGE GLTHQNVLFF KQKPYHKPFS AAGRIFRLWD DLGTSQEEEE
490 500 510 520 530 540
RGDMASSIRL FMKEYKLSTV EEARSCVLEE ISRLWKDLNE GLISIKDALP LTIVKVALNI
550 560 570
ARTSQVVYKH EQHTYMLSVD NYVEALFFTP LLSS